NCT00238953View on ClinicalTrials.gov

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Renal Transplantation
Interventions
DRUG

Enteric-Coated Mycophenolate Sodium (EC-MPS)

Trial Locations (1)

Unknown

Novartis, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY